
The overlaps between segmental vitiligo (SV) and nonsegmental vitiligo (NSV) suggest the underlying features of SV, which may be helpful for treating SV. In this study, 379 vitiligo patients were recruited and divided into SV (33.2%), mild to moderate NSV (M‐NSV, affected body affected area [BSA] ≤10%, 34.0%) and severe NSV (S‐NSV, affected BSA > 10%, 32.7%) groups. Demographics and clinical data were collected through in‐person interviews. The disease activity, progression and prognosis were assessed through 6 months’ follow‐up. Serum cytokines profile and tissue‐infiltrating immune cells was measured by ELISA assay and immunofluorescence, respectively. The SV exhibited lower rates of autoimmune comorbidities and recurrence than the S‐NSV, but performed similar to the M‐NSV...
Like
Save
Share